Pfizer Inc. (PFE): Price and Financial Metrics

Pfizer Inc. (PFE): $27.76

0.21 (+0.76%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

PFE Price/Volume Stats

Current price $27.76 52-week high $42.22
Prev. close $27.55 52-week low $25.76
Day low $27.69 Volume 33,182,500
Day high $28.09 Avg. volume 42,308,828
50-day MA $27.96 Dividend yield 6.07%
200-day MA $32.89 Market Cap 156.74B

PFE Stock Price Chart Interactive Chart >

PFE POWR Grades

  • PFE scores best on the Value dimension, with a Value rank ahead of 93.93% of US stocks.
  • The strongest trend for PFE is in Stability, which has been heading down over the past 26 weeks.
  • PFE ranks lowest in Growth; there it ranks in the 1st percentile.

PFE Stock Summary

  • PFE has a higher market value than 98.83% of US stocks; more precisely, its current market capitalization is $167,867,867,171.
  • PFIZER INC's stock had its IPO on January 1, 1986, making it an older stock than 92.92% of US equities in our set.
  • As for revenue growth, note that PFE's revenue has grown -31.24% over the past 12 months; that beats the revenue growth of merely 8.64% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to PFIZER INC, a group of peers worth examining would be AMGN, CSCO, NFLX, TXN, and INTU.
  • Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.

PFE Valuation Summary

  • In comparison to the median Healthcare stock, PFE's price/sales ratio is 9.09% higher, now standing at 2.4.
  • Over the past 243 months, PFE's price/sales ratio has gone down 4.9.

Below are key valuation metrics over time for PFE.

Stock Date P/S P/B P/E EV/EBIT
PFE 2023-12-29 2.4 1.7 15.5 21.5
PFE 2023-12-28 2.4 1.7 15.5 21.5
PFE 2023-12-27 2.4 1.7 15.4 21.4
PFE 2023-12-26 2.3 1.7 15.3 21.3
PFE 2023-12-22 2.3 1.7 15.3 21.2
PFE 2023-12-21 2.3 1.6 15.2 21.2

PFE Growth Metrics

    Its 4 year net cashflow from operations growth rate is now at -11.47%.
  • The 3 year revenue growth rate now stands at 71.5%.
  • Its 5 year cash and equivalents growth rate is now at -46.98%.
Over the past 49 months, PFE's revenue has gone up $46,303,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 99,676 26,599 29,771
2022-06-30 101,132 31,454 29,309
2022-03-31 92,367 34,583 24,966
2021-12-31 81,288 32,580 21,979
2021-09-30 63,600 32,291 19,180
2021-06-30 51,637 23,552 13,228

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
  • PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
  • XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.312 0.704 0.149
2021-04-04 0.265 0.763 0.116
2020-12-31 0.247 0.793 0.099
2020-09-27 0.282 0.799 0.083
2020-06-28 0.288 0.799 0.181
2020-03-29 0.307 0.799 0.200

PFE Price Target

For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $46.03 Average Broker Recommendation 1.8 (Hold)

Pfizer Inc. (PFE) Company Bio


Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.


PFE Latest News Stream


Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream


Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about PFIZER INC that investors may wish to consider to help them evaluate PFE as an investment opportunity.

The 500 Top Stocks to Buy for 2024, Ranked by AI

These are the very best stocks to buy for 2024 for any investor, according to Tom Yeung's MarketMasterAI system.

Thomas Yeung on InvestorPlace | December 29, 2023

Top Performers: 7 High-Efficiency Stocks With Stellar Profit Per Employee Ratios

Inundated with myriad ways of assessing publicly traded companies, one unique metric could intrigue investors seeking opportunities in 2024 and that would be high-efficiency stocks.

Josh Enomoto on InvestorPlace | December 28, 2023

Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.

While Novo Nordisk dominates the weight-loss market, there are two other stocks to consider as well.

Yahoo | December 28, 2023

S&P 500 Is Nearing a Record High. This Could Derail It in 2024.

Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day.

Yahoo | December 28, 2023

Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?

COVID-19 products Comirnaty and Paxlovid are no longer Pfizer's crown jewels. But that's OK.

Yahoo | December 28, 2023

Read More 'PFE' Stories Here

PFE Price Returns

1-mo 1.06%
3-mo -6.51%
6-mo -21.00%
1-year -30.09%
3-year -7.56%
5-year -17.01%
YTD -2.13%
2023 -41.26%
2022 -10.41%
2021 66.70%
2020 3.23%
2019 -6.91%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!